Long-chain non-coding RNA MYC-AS1 expression Northern blot detection primer and kit
A RNAMYC-AS1, long-chain non-coding technology, applied in the field of molecular biology
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Example 1. Determination of the full-length sequence of MYC-AS1.
[0026] (1) Identify the 5' and 3' end sequences of MYC-AS1;
[0027] Mainly provided by Takara Corporation RACE 5' / 3'Kit kit to complete.
[0028] First, use Reagent was used to extract total RNA from the human colon cancer cell line HCT116, and then the genome was depleted with RNase-freeDNase I. Under the action of SMARTScribeReverse Transcriptase (provided by the kit), 1 μg of the genome-removed RNA was reverse-transcribed to synthesize 5′- or 3′-RACE products.
[0029] Then, follow Instructions for the operation of the RACE 5' / 3'Kit kit, using the universal primer UPM and 5'-end or 3'-end gene-specific primers (gene-specific primers, GSP) for PCR amplification, cloning and sequencing to obtain MYC- 5' end and 3' end sequences of AS1. Wherein, the nucleotide sequence of the 5'-end or 3'-end gene-specific primer used is as follows:
[0030] MYC-AS1-5-race:
[0031] 5'-CCACAGCAAAACCTCCTCACAGC...
Embodiment 2
[0040] Example 2, MYC-AS1 overexpression vector construction.
[0041] In Example 2, the full-length MYC-AS1 sequence obtained in Example 1 was used to construct a MYC-AS1 overexpression plasmid.
[0042] Specifically include the following steps:
[0043](1) From human colon cancer cell line HCT116, use Reagent was used to extract total RNA, and RNase-free DNase I was used to deplete the genome. It was reverse transcribed into a cDNA product using the PrimeScript RT reagent Kit.
[0044] (2) Using the cDNA product obtained in step (1) of Example 2 as a template, use a high-fidelity enzyme to amplify the full-length sequence of MYC-AS1, wherein the primers MYC-AS1-HindIII-F and MYC-AS1-BamHI- The nucleotide sequence of R is as follows:
[0045] MYC-AS1-HindIII-F:
[0046] 5'-cccaagcttGCCTTTTCATTGTTTTCCA-3' (SEQ ID NO.4)
[0047] MYC-AS1-BamHI-R:
[0048] 5'-cgcggatccCCTTTTTTTAAGACGGAGTC-3' (SEQ ID NO.5)
[0049] The reaction system includes: 100ng of the cDNA product o...
Embodiment 3
[0052] Example 3. Analysis of the ability of MYC-AS1 to inhibit the expression of the proto-oncogene c-myc gene.
[0053] In this Example 3, using the pcDNA3.1-MYC-AS1 overexpression plasmid obtained from Example 2, the ability of MYC-AS1 to inhibit the expression of the proto-oncogene c-myc gene was evaluated by fluorescent quantitative PCR and Western-blot methods .
[0054] Specifically include the following steps:
[0055] (1) Human colon cancer cell line HCT116 cells were inoculated into 6-well cell culture plates, and then transfected with pcDNA3.1-MYC-AS1 overexpression plasmid. Simultaneous transfection of pcDNA3.1-EGFP overexpression plasmid was used as vector control.
[0056] (2) 48 hours after transfection, the cells were collected;
[0057] (3) The total RNA of the cells was extracted, and the expression level of the proto-oncogene c-myc in the cells was detected by a fluorescent quantitative PCR method.
[0058] (4) Extract the total protein of the cells, and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com